Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Marc Nguyen-Tat, ?; Galle, Peter R.; Lammert, Frank et al.
Liver Precaution-Program SEAL Structured Early Detection of asymptomatic Liver Fibrosis and Liver Cirrhosis in Rhineland-Palatinate and SaarlandGASTROENTEROLOGE. Bd. 13. H. 3. 2018 S. 249-250
Nestle, U.; Schimek-Jasch, T.; Kremp, S. et al.
Locally Advanced Non-Small Cell Lung Cancer: Excellent Results of Isotoxic Dose Escalation after FDG-PET-Guided Target Volume Reduction - Results of a Prospective Randomized Multicenter TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. Bd. 102. H. 3. 2018 S. S16-S16
Langer, Thorsten; Grabow, Desiree; Kaatsch, Peter et al.
Long-Term Follow-Up in Childhood Cancer Survivors Position paper 2018 of the working group "long-term follow-up" of the Society of Pediatric Oncology and Hematology (GPOH) on long-term surveillance, long-term follow-up and late effect evaluation in pediatric oncology patientsKLINISCHE PADIATRIE. Bd. 230. H. 6. 2018 S. 291-298
Hechtner, Marlene; Krause, Mechthild; Koenig, Jochem et al.
Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trialRADIOTHERAPY AND ONCOLOGY. Bd. 126. H. 2. 2018 S. 283-290
Gehrke, Nadine; Nagel, Michael; Straub, Beate K. et al.
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationAMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY. Bd. 314. H. 3. 2018 S. G319-G333
Pons, Miriam; Reichardt, Claudia M.; Hennig, Dorle et al.
Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cellsARCHIVES OF TOXICOLOGY. Bd. 92. H. 6. 2018 S. 2119-2135
Reinisch, M.; Seiler, S.; Hauzenberger, T. et al.
Male-GBG54: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen plus /- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor plus GnRHa in male breast cancer patientsCANCER RESEARCH. Bd. 78. H. 4. 2018
Thill, Marc; Schmidt, Marcus
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. Bd. 10. 2018
Eckes, L.; Droge, L. A.; Fullborn, T. et al.
Management of patients with gynecological sarcoma - a survery among gynecologists within the framework of the German Registry of Gynecological Sarcoma (REGSA)ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 194-195
Sellmer, Andreas; Stangl, Hubert; Beyer, Mandy et al.
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 InhibitorsJOURNAL OF MEDICINAL CHEMISTRY. Bd. 61. H. 8. 2018 S. 3454-3477